SUMMIT European Cannabis Insights Summit 2026 — Exclusive industry intelligence Register Now
EVENT Cannabis Europa London 2026 — Europe's cannabis industry unites Get Tickets

Recent Searches

    New CFO Ranjan Kalia appointed to Curaleaf

    By

    Curaleaf thanks former chief financial officer (CFO) and welcomes new appointment of Ranjan Kalia. 

    Kalia joined international provider of cannabis products Curaleaf Holdings, Inc. as CFO on 19 July. He succeeded Michael Carlotti who has stepped down for medical reasons.

    Commenting on the appointment, Curaleaf CFO, Kalia, said: “I am truly honoured to be joining the Curaleaf team at this exciting time in the company’s evolution. As Curaleaf has established itself as the global pure play cannabis leader, the company remains in the very early innings of its long-term potential development in this dynamic and fast growing industry. 

    “I look forward to partnering with the entire Curaleaf team to continue executing on its track record for financial performance, strong balance sheet and robust engagement with the financial community.”

    Leadership expertise

    Kalia will bring a wealth of expertise to Curaleaf after having served as executive vice president and chief financial officer of Virtusa Corp, a global provider of digital strategy, and extensive experience and knowledge across corporate tax regulations, US SEC regulations and Sarbanes Oxley compliance requirements.

    He has also spent eight years with EMC Corporation serving in various roles including vice president of finance and chief financial officer – Asia-Pacific region, and has held senior financial controller and audit positions at GE Capital, Pepsi Cola Co., and Pricewaterhouse Coopers.

    Boris Jordan, Executive Chairman of the Board of Curaleaf, commented: “On behalf of the Board of Directors and the executive leadership team I want to personally thank Mike for his tremendous commitment and contributions to Curaleaf. During Mike’s tenure as Chief Financial Officer he delivered exceptional financial performance management while ensuring the Company maintained its commitment to a strong balance sheet to help drive our business and meet our goals. Mike played an important role in setting the foundation for our future success; moreover, he’s an exceptional professional and friend. We wish him all the best for a prompt and full recovery.”

    Joseph Bayern, Chief Executive Officer of Curaleaf, commented: ”I am pleased to welcome Ranjan to the Curaleaf executive leadership team. With over thirty years of experience in executive finance positions at complex multinational companies, Ranjan brings a wealth of expertise which will be instrumental in helping fuel our continued growth. He’s joining us at a very exciting time for our company and I look forward to working with him.”

    [activecampaign form=31]

    10 June 2026 · Berlin Sales end May 29

    European Cannabis
    Insights Summit

    From €216

    200+ industry leaders. Exclusive German market data. A half-day briefing for B2B operators in Europe's most important emerging cannabis market.

    Stephanie Price

    Stephanie is a journalist for Business of Cannabis, writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, where her magazine ‘Game Theory’ focused on developments and disruptors over the coming decade including cannabis, psychedelics, blockchain/crypto and free speech. In 2015 Stephanie received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, and a certificate from the Medical Cannabis Clinicians Society on “Medical Cannabis Explained”.

    The Briefing / Newsletter

    Insights
    you don't want
    to miss.

    A comprehensive, thoughtfully curated overview of the stories defining today's cannabis sector — breaking news, investigative features, expert commentary, and context-rich analysis to help you navigate events with clarity and confidence.

    • Policy & regulation
    • Markets & deals
    • Clinical & science
    Subscribe free